Chakrabarti cheers Life of Pi’s big wins at Olivier awards
By AMIT ROYApr 11, 2022
ACCLAIMED Asian director Lolita Chakrabarti and her team were celebrating on Monday (11), after the West End play, Life of Pi, scooped five awards at the prestigious Laurence Olivier awards the previous night (10).
The stage adaptation of Yann Martel’s Booker Prize-winning novel has won the Best Actor accolade for Hiran Abeysekera and Best New Play for writer and director Lolita Chakrabarti at the theatre awards at the Royal Albert Hall in central London
on Sunday (10).
In her acceptance speech, Chakrabarti she said the continued success of Life of Pi was a “testament to the story” created by Martel, and described it as an “absolute modern classic”.
She noted his “graciousness in giving me the freedom to tell the story as I wanted”. “He said, ‘I don’t know about theatre, you do what you do and have the book,’” Chakrabarti told the audience.
Lolita Chakrabarti with the Best New Play award (credit: Jeff Spicer/Getty Images)
“I think that understanding of other forms of artistry and his generosity has made the film what it was and the play what it is. It all comes down from his book really.” Some months ago when Martel and Chakrabarti discussed Life of Pi after press night at Wyndham’s Theatre, the author confessed he almost preferred the stage version.
On Sunday night, Chakrabarti also thanked her husband, actor Adrian Lester. “When I started writing, he was my biggest fan and encouraged me completely. When all the doors were shut, he said, ‘Keep knocking, because they’ll open,’” she recalled.
Asian actor Abeysekera plays Pi Patel, a 16-year-old who journeys across the Pacific Ocean for 227 days with a 450lb ferocious Royal Bengal tiger, Richard Parker, who are the only survivors from a shipwreck. The tiger had come from a zoo in Pondicherry, south India.
Abeysekera performs on stage with the cast of Life of Pi (credit: Jeff Spicer/Getty Images)
In an emotional speech, Abeysekera, the show’s undoubted star who is on stage for the entire length of the two-hour performance, said he was “overwhelmed” to win Best Actor. He also admitted taking on the lead role of Pi was initially “quite a scary proposition” as the book was so beloved, but said cast members realised they had “something special” after their first dress run. Abeysekera also paid tribute to his home country of Sri Lanka, which he said was going through a “tough time now... I think of you and wish I was there with you”.
The seven puppeteers who skilfully manoeuvre the mock-up of the tiger – three are required at any one time to handle the animal’s head, heart and hind – were jointly named Best Supporting Actor, the first time this has happened in the history of the Olivier awards. The prize was picked up by Fred Davis, Daisy Franks, Tom Stacy, Romina Hytten, Scarlet Wilderink, Tom Larkin and actor Habib Nasib Nader, who provides the voice of the tiger and appears as a cook as well.
Hytten, who first started learning puppetry as an 11-year-old, dedicated the award to all puppeteers.
She said: “Shout out has to be given to War Horse – three of us in this team were in War Horse. It helped put puppetry in the realm of a character that the audience can relate to. This award feels so much bigger than just the seven of us – it’s for all puppeteers.”
Stacy echoed her sentiments: “We’re not just the first puppets to win, but the first to have been nominated for the award. As a tiger team, it couldn’t feel more right and it’s exciting for the future of theatre.”
Finn Caldwell (left) and Tim Hatley withthe Best Set Design award (credit: Gareth Cattermole/Getty Images)
Puppet designers for the show, Nick Barnes and Finn Caldwell, previously spoke to the Telegraph about the portrayal of Richard Parker, saying that just being nominated for the award would open doors for other puppet shows in future.
“We’ve been hoping for a reaction like the Olivier awards for so long”, said Caldwell, puppetry and movement director.
He added that the National Theatre’s production of Michael Morpurgo’s War Horse helped to change the image of puppetry, although there were still challenges. He said: “The ‘p-word’ is difficult. When I hear the word ‘puppet’ I flinch – I assume people are making associations with Punch and Judy. It’s not glamorous. It’s hard to go, ‘Hey, I’m a puppeteer’. I think all that’s now changing, though. If you say, “I was the tiger last night”, the reaction you may well get is ‘Oh, my god!’”
Tim Lutkin (left) and Andrzej Goulding with the Best Lighting design award (credit: Gareth Cattermole/Getty Images)
The pair revealed they researched for the show by studying videos of animals and taking trips to London zoo. They created the tiger puppet from foam, plywood, aluminium and nylon, with elasticated bungee cords for the joints.
In the Best Set Design category, Life of Pi also won awards for Tim Hatley for Design and Finn Caldwell for Puppets. For Best Lighting Design, the Life of Pi winners were Tim Lutkin and Andrzej Goulding. The play, which has survived two stoppages caused by the pandemic, is currently being performed at Wyndham’s Theatre in London’s West End.
The novel was also adapted into a film in 2012 which starred Suraj Sharma and won four Oscars. Life of Pi represents British theatre at its best, but it goes deeper than entertainment for its poses a fundamental question: is there a God?
After watching the two-hour play, the audience is encouraged to believe that there is, although, to be sure, people are left to make up their own minds.
The cast of Life of Pi on stage (credit: Jeff Spicer/Getty Images)
Pi tells his story in flashback from a hospital bed after he and Richard Parker wash up in Mexico at journey’s end. The boat’s previous occupant had been a hyena which had been killed by the tiger. But this seemed like natural justice because the hyena had devoured a zebra, Black & White, and a much loved orangutan, Orange Juice.
Pi’s account of “co-habitation” with a tiger is just not believed by a Mr Okamoto, who has come from Japan to debrief the boy, the only survivor after the sinking of the Tsimtsum. This was the Japanese ship ferrying the Patel family zoo from Pondicherry in south India to a new life in Canada.
But the alternative account was horrific, which was that the hyena, zebra and orangutan had represented the ship’s chef, a sailor and Pi’s mother, Amma. The chef had killed and eaten the sailor and Amma, and Pi, in turn, had killed their killer. Whether he, too, had engaged in cannibalism is left unsaid.
“Which is the better story?” asks Pi.
When the novel came out in 2001, Martel received a two paragraph note from the White House, which said: “My daughter and I just finished reading Life of Pi together. Both of us agreed we prefer the story with animals. It is a lovely book — an elegant proof of God, and the power of storytelling. Thank you.” It was signed Barack Obama.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.